Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency A Brooks-Wilson, M Marcil, SM Clee, LH Zhang, K Roomp, M van Dam, ... Nature genetics 22 (4), 336-345, 1999 | 2128 | 1999 |
Hyperinsulinemia drives diet-induced obesity independently of brain insulin production AE Mehran, NM Templeman, GS Brigidi, GE Lim, KY Chu, X Hu, ... Cell metabolism 16 (6), 723-737, 2012 | 609 | 2012 |
Common Genetic Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease SM Clee, AH Zwinderman, JC Engert, KY Zwarts, HOF Molhuizen, ... Circulation 103 (9), 1198-1205, 2001 | 433 | 2001 |
Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux M Marcil, A Brooks-Wilson, SM Clee, K Roomp, LH Zhang, L Yu, ... The Lancet 354 (9187), 1341-1346, 1999 | 419 | 1999 |
Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes SM Clee, JJP Kastelein, M van Dam, M Marcil, K Roomp, KY Zwarts, ... The Journal of clinical investigation 106 (10), 1263-1270, 2000 | 389 | 2000 |
Increased ABCA1 activity protects against atherosclerosis C Fievet, G Castro, ER James, N Hennuyer, SM Clee, N Bissada, ... The Journal of clinical investigation 110 (1), 35-42, 2002 | 377 | 2002 |
The genetic landscape of type 2 diabetes in mice SM Clee, AD Attie Endocrine reviews 28 (1), 48-83, 2007 | 288 | 2007 |
Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study MJ van Dam, E de Groot, SM Clee, GK Hovingh, R Roelants, ... The Lancet 359 (9300), 37-41, 2002 | 259 | 2002 |
Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids G Labouèbe, S Liu, C Dias, H Zou, JCY Wong, S Karunakaran, SM Clee, ... Nature neuroscience 16 (3), 300-308, 2013 | 255 | 2013 |
Obesity genetics in mouse and human: back and forth, and back again FT Yazdi, SM Clee, D Meyre PeerJ 3, e856, 2015 | 246 | 2015 |
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor … V Bocher, ER James, SM Clee, LH Zhang, BR Leavitt, B Tan, ... Journal of biological chemistry 276 (36), 33969-33979, 2001 | 228 | 2001 |
Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus SM Clee, BS Yandell, KM Schueler, ME Rabaglia, OC Richards, ... Nature genetics 38 (6), 688-693, 2006 | 218 | 2006 |
GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis SJ Kim, C Nian, S Karunakaran, SM Clee, CM Isales, CHS McIntosh PloS one 7 (7), e40156, 2012 | 181 | 2012 |
ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels KY Zwarts, SM Clee, AH Zwinderman, JC Engert, R Singaraja, O Loubser, ... Clinical genetics 61 (2), 115-125, 2002 | 170 | 2002 |
Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency MR Hayden, SM Clee, A Brooks-Wilson, J Genest Jr, A Attie, ... Current opinion in lipidology 11 (2), 117-122, 2000 | 161 | 2000 |
Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function H Zhang, H Henderson, SE Gagne, SM Clee, L Miao, G Liu, MR Hayden Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 1302 (2 …, 1996 | 148 | 1996 |
Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis SM Clee, N Bissada, F Miao, L Miao, AD Marais, HE Henderson, ... Journal of lipid research 41 (4), 521-531, 2000 | 128 | 2000 |
Genetic and genomic studies of the BTBR ob/ob mouse model of type 2 diabetes SM Clee, ST Nadler, AD Attie American journal of therapeutics 12 (6), 491-498, 2005 | 123 | 2005 |
SORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouse MO Goodarzi, DM Lehman, KD Taylor, X Guo, J Cui, MJ Quinones, ... diabetes 56 (7), 1922-1929, 2007 | 115 | 2007 |
Compositions and methods for modulating HDL cholesterol and triglyceride levels M Hayden, A Brooks-Wilson, S Pimstone, S Clee US Patent App. 10/745,377, 2004 | 111 | 2004 |